Evofem Biosciences Inc. (EVFM)
$0.01
$-0.06
(-88.43%)
As on 31-Aug-2026 15:50EDT
Market cap
$1 Mln
Revenue (TTM)
$18 Mln
P/E Ratio
--
P/B Ratio
8.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-3.9 %
-
ROCE
-- %
-
Industry P/E
37.32
-
EV/EBITDA
25.6
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.1
-
Face value
--
-
Shares outstanding
132,530,081
10 Years Aggregate
CFO
$-514.41 Mln
EBITDA
$-441.71 Mln
Net Profit
$-653.95 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Evofem Biosciences (EVFM)
| -- | -- | -- | -- | -65.7 | -91.1 | -75.6 |
|
BSE Sensex*
| -9.2 | -1.6 | 2.8 | -3.7 | 5.8 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
Evofem Biosciences (EVFM)
| -84.4 | -60.9 | 47.3 | -64.0 | 74.1 | -19.4 | -81.4 |
|
S&P Small-Cap 600
| 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 | -3.4 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Evofem Biosciences (EVFM)
|
0.0 | 1.1 | 18.1 | -15.3 | -26.0 | -- | -- | 8.4 |
| 17.5 | 6,109.1 | 3,117.6 | 157.4 | 14.7 | -- | 37.3 | 190.1 | |
| 198.5 | 10,424.8 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 129.6 | |
| 76.6 | 14,974.8 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 113.4 | 12,310.3 | 830.8 | 54.9 | 3.2 | 8.1 | 264.8 | 17.9 | |
| 12.1 | 10,087.6 | 332,834.2 | 33,166.6 | 11.1 | 8.9 | 28.8 | 2.5 | |
| 23.9 | 11,971.8 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.8 | |
| 284.1 | 5,591.7 | 290.5 | 197.2 | 82.5 | 19.9 | 28.9 | 5.9 | |
| 68.2 | 6,058.9 | 450.9 | 138.6 | 39.1 | 115.6 | 50.1 | 32.1 | |
| 139.0 | 8,865.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 21.5 |
Shareholding Pattern
View DetailsAbout Evofem Biosciences (EVFM)
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive... vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California. Read more
-
Interim Chair, President & CEO
Ms. Saundra Pelletier
-
Interim Chair, President & CEO
Ms. Saundra Pelletier
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Evofem Biosciences (EVFM)
What is the current share price of Evofem Biosciences Inc (EVFM) Today?
The share price of Evofem Biosciences Inc (EVFM) is $0.01 (NASDAQ) as of 31-Aug-2026 15:50 EDT. Evofem Biosciences Inc (EVFM) has given a return of -65.66% in the last 3 years.
What is the current PB & PE ratio of Evofem Biosciences Inc (EVFM)?
Since, TTM earnings of Evofem Biosciences Inc (EVFM) is negative, P/E ratio is not available.
The P/B ratio of Evofem Biosciences Inc (EVFM) is 8.37 times as on 28-Aug-2026, a 8 premium to its peers’ median range of 7.75 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-- |
-- |
2024 |
-- |
-- |
2023 |
0.02 |
-0.01 |
2022 |
0.00 |
0.00 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Evofem Biosciences Inc (EVFM)?
The 52-week high and low of Evofem Biosciences Inc (EVFM) are Rs 0.01 and Rs 0.01 as of 01-Sep-2026.
What is the market cap of Evofem Biosciences Inc (EVFM)?
Evofem Biosciences Inc (EVFM) has a market capitalisation of $ 1 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Evofem Biosciences Inc (EVFM)?
Before investing in Evofem Biosciences Inc (EVFM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.